Irving K. Hwang

443 total citations
7 papers, 264 citations indexed

About

Irving K. Hwang is a scholar working on Statistics and Probability, Management Science and Operations Research and Immunology. According to data from OpenAlex, Irving K. Hwang has authored 7 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Statistics and Probability, 4 papers in Management Science and Operations Research and 2 papers in Immunology. Recurrent topics in Irving K. Hwang's work include Statistical Methods in Clinical Trials (5 papers), Optimal Experimental Design Methods (4 papers) and Biosimilars and Bioanalytical Methods (2 papers). Irving K. Hwang is often cited by papers focused on Statistical Methods in Clinical Trials (5 papers), Optimal Experimental Design Methods (4 papers) and Biosimilars and Bioanalytical Methods (2 papers). Irving K. Hwang collaborates with scholars based in United States, Switzerland and Japan. Irving K. Hwang's co-authors include John S. de Cani, Weichung Joe Shih, Myron Chang, Weichung Joseph Shih, A. Lawrence Gould, E.S. Lee, Chunlin Huang, E. Stanley Lee, George W. Williams and Robert L. Davis and has published in prestigious journals such as Statistics in Medicine, International Journal of Engineering Science and JAWRA Journal of the American Water Resources Association.

In The Last Decade

Irving K. Hwang

7 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irving K. Hwang United States 6 153 85 56 50 26 7 264
Michael O’Kelly United States 13 355 2.3× 28 0.3× 180 3.2× 48 1.0× 11 0.4× 27 548
Joan Gurian United States 9 119 0.8× 27 0.3× 33 0.6× 30 0.6× 22 0.8× 13 328
Bohdana Ratitch United States 13 406 2.7× 25 0.3× 184 3.3× 34 0.7× 14 0.5× 28 614
Moreno Ursino France 11 150 1.0× 54 0.6× 52 0.9× 20 0.4× 14 0.5× 42 324
Yeongjin Gwon United States 9 147 1.0× 33 0.4× 61 1.1× 20 0.4× 38 1.5× 30 387
Esra Akdenız Türkiye 11 144 0.9× 32 0.4× 10 0.2× 50 1.0× 20 0.8× 61 392
Gorana Capkun-Niggli Switzerland 9 204 1.3× 38 0.4× 87 1.6× 50 1.0× 9 0.3× 14 514
Antoine Chambaz France 9 88 0.6× 26 0.3× 14 0.3× 7 0.1× 37 1.4× 25 220
Jonathan Monteleone United States 5 95 0.6× 16 0.2× 48 0.9× 4 0.1× 7 0.3× 8 272
Dalho Kim South Korea 8 62 0.4× 32 0.4× 40 0.7× 7 0.1× 30 1.2× 20 225

Countries citing papers authored by Irving K. Hwang

Since Specialization
Citations

This map shows the geographic impact of Irving K. Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irving K. Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irving K. Hwang more than expected).

Fields of papers citing papers by Irving K. Hwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irving K. Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irving K. Hwang. The network helps show where Irving K. Hwang may publish in the future.

Co-authorship network of co-authors of Irving K. Hwang

This figure shows the co-authorship network connecting the top 25 collaborators of Irving K. Hwang. A scholar is included among the top collaborators of Irving K. Hwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irving K. Hwang. Irving K. Hwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hwang, Irving K., et al.. (1999). Design Issues in Noninferiority/Equivalence Trials. Drug Information Journal. 33(4). 1205–1218. 69 indexed citations
2.
Chang, Myron, et al.. (1998). Group sequential designs using both type I and type II error probability spending functions. Communication in Statistics- Theory and Methods. 27(6). 1323–1339. 19 indexed citations
3.
Williams, George W., Robert L. Davis, Albert J. Getson, et al.. (1993). Monitoring of clinical trials and interim analyses from a drug Sponsor's point of view. Statistics in Medicine. 12(5-6). 481–492. 13 indexed citations
4.
Hwang, Irving K., Weichung Joe Shih, & John S. de Cani. (1990). Group sequential designs using a family of type I error probability spending functions. Statistics in Medicine. 9(12). 1439–1445. 136 indexed citations
5.
Shih, Weichung Joseph, A. Lawrence Gould, & Irving K. Hwang. (1989). The analysis of titration studies in phase III clinical trials. Statistics in Medicine. 8(5). 583–591. 13 indexed citations
6.
Lee, E.S., Chunlin Huang, & Irving K. Hwang. (1972). Applying quasilinearization to the nonlinear analysis of elastic bars. International Journal of Engineering Science. 10(1). 33–44. 9 indexed citations
7.
Lee, E. Stanley & Irving K. Hwang. (1971). DYNAMIC MODELING OF STREAM QUALITY BY INVARIANT IMBEDDING1. JAWRA Journal of the American Water Resources Association. 7(1). 102–114. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026